Singapore, 30 November 2011 ‐ Biosensors International Group, Ltd. (“Biosensors”, “Company”, Bloomberg: BIG SP) today announced Wellford Capital Limited, a wholly‐owned subsidiary of Weigao International Medical Co. Limited, which is in turn a wholly‐owned subsidiary of Shandong Weigao Group Medical Polymer Company Limited (“Shandong Weigao”) has fully exercised its rights in converting the US$120 million principal amount of 4% convertible notes due 2014 held in Biosensors.
As a result, Shandong Weigao will become the single largest shareholder of Biosensors with 370 million shares, or approximately 21.6% of the Company.
----------------
Createwealth8888:
due 2014. Why convert so early?
Posts
End of Year 2024 Update: Buying more Business Trust and REIT For Dividend
-
As said in my past posts, it is likely I would purchase more Asia Pay TV
Trust (APTT). I did just that. Other purchases were UnitedHampshire REIT
and Yan...
4 hours ago
No comments:
Post a Comment